Substituted 2-hydrogen-pyrazole derivative serving as anticancer drug

Disclosed is a substituted 2-hydrogen-pyrazole derivative serving as a selective CDK4/6 inhibitor. Specifically, formula (I) or a pharmaceutically acceptable salt thereof serves as a selective CDK4/6 inhibitor.